The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...